Certified by Founder Lodge
Triveni Bio
United States - Cambridge, Massachusetts
START UP
1 Disclosed Funding Rounds $92,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Triveni Bio is a biotech company pioneering a genetics-informed precision medicine approach to develop functional antibodies for the treatment of I&I disorders. The company’s approach establi
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 27 ,2023 | Series A | $92,000,000 | |
| October, 03 ,2024 | Series B | $115,000,000.00 |
OrbiMed
Polaris Partners
Atlas Venture
The Invus Group
Viking Global Investors
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)